Proteomics-Based Strategies To Identify Proteins Relevant to Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

Proteomics-Based Strategies To Identify Proteins Relevant to Chronic Lymphocytic Leukemia

Published:2014-07-14 Issue:11 Volume:13 Page:5051-5062
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Alsagaby Suliman A.¹²,Khanna Sanjay³,Hart Keith W.³,Pratt Guy⁴,Fegan Christopher¹,Pepper Christopher¹,Brewis Ian A.³,Brennan Paul¹

Affiliation:

1. Institute of Cancer & Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, United Kingdom

2. Department of Medical Laboratory, College of Science, Majmaah University, King Fahd Street, PO Box 1712, Al-Zulfi, Riyadh Region, 11932, Kingdom of Saudi Arabia

3. TIME Institute, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, United Kingdom

4. CRUK Institute for Cancer Studies, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, United Kingdom

Funder

Ministry of Higher Education, Saudi Arabia

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr5002803

Reference62 articles.

1. CLL Biology and Prognosis

2. Chronic Lymphocytic Leukemia

3. Chronic lymphocytic leukemia: A review of some new aspects of the biology, factors influencing prognosis and therapeutic options

4. Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia

5. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia;Journal of Personalized Medicine;2024-08-06

2. Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy;Clinical Cancer Research;2023-02-03

3. Proteomic Portrait of Human Lymphoma Reveals Protein Molecular Fingerprint of Disease Specific Subtypes and Progression;Phenomics;2022-12-12

4. In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia;Scientific Reports;2022-10-21

5. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential;Frontiers in Oncology;2022-10-18